調查批次:CHT2016-04 | 檢體寄出日期:2016-10-24 | 報告回收截止日期:2016-10-31 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 0 |
2 |
5 |
2.46 |
-0.40 |
-14.0 |
-1.7 |
-0.5 |
-58 |
1.86 |
-0.14 |
-7.0 |
-0.9 |
-0.2 |
-29 |
RH07b | RH07 | 8 |
2 |
3 |
3.54 |
0.68 |
23.8 |
3.0 |
1.1 |
99 |
2.17 |
0.17 |
8.5 |
1.1 |
1.2 |
35 |
RH14 | RH14 | 4 |
2 |
3 |
2.81 |
-0.05 |
-1.7 |
-0.2 |
0.0 |
-7 |
2.07 |
0.07 |
3.5 |
0.4 |
0.7 |
15 |
RH15 | RH15 | 7 |
2 |
5 |
2.34 |
-0.52 |
-18.2 |
-2.3 |
-0.7 |
-75 |
1.81 |
-0.19 |
-9.5 |
-1.2 |
-0.4 |
-40 |
CL009 | CL009 | 4 |
2 |
5 |
2.58 |
-0.28 |
-9.8 |
-1.2 |
-0.4 |
-41 |
1.85 |
-0.15 |
-7.5 |
-0.9 |
-0.2 |
-31 |
CL010 | CL010 | 3 |
2 |
5 |
2.18 |
-0.68 |
-23.8 |
-3.0 |
-1.0 |
-99 |
1.61 |
-0.39 |
-19.5 |
-2.4 |
-1.3 |
-81 |
CL012 | CL012 | 5 |
2 |
3 |
3.84 |
0.98 |
34.3 |
4.3 |
1.6 |
142 |
1.82 |
-0.18 |
-9.0 |
-1.1 |
-0.3 |
-38 |
CL013 | CL013 | 2 |
2 |
5 |
2.39 |
-0.47 |
-16.4 |
-2.0 |
-0.6 |
-68 |
1.72 |
-0.28 |
-14.0 |
-1.8 |
-0.8 |
-58 |
CL015 | CL015 | 4 |
2 |
3 |
3.21 |
0.35 |
12.2 |
1.5 |
0.6 |
51 |
2.18 |
0.18 |
9.0 |
1.1 |
1.2 |
38 |
Median of RIA Group |
2.58 |
1.85 |
||||||||||||||
Range of RIA Group |
2.18 - 3.84 |
1.61 - 2.18 |
||||||||||||||
Robust mean of RIA Group |
2.81 ( n = 9 ) |
1.90 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.65 |
0.23 |
||||||||||||||
CV of RIA Group |
23.1% |
12.1% |
||||||||||||||
Median of European RIA Labs |
2.46 ( n = 103 ) |
1.83 ( n = 99 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.24 - 2.84 |
1.58 - 2.07 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
4 |
9 |
2.99 |
0.13 |
4.5 |
0.6 |
0.9 |
19 |
2.18 |
0.18 |
9.0 |
1.1 |
1.3 |
38 |
RH02c | RH02 | 7 |
4 |
1 |
2.07 |
-0.79 |
-27.6 |
-3.4 |
-1.2 |
-114 |
1.58 |
-0.42 |
-21.0 |
-2.6 |
-0.9 |
-88 |
RH06 | RH06 | 7 |
4 |
9 |
3.07 |
0.21 |
7.3 |
0.9 |
1.1 |
30 |
2.19 |
0.19 |
9.5 |
1.2 |
1.3 |
40 |
RH07a | RH07 | 2 |
4 |
2 |
2.52 |
-0.34 |
-11.9 |
-1.5 |
-0.2 |
-49 |
1.58 |
-0.42 |
-21.0 |
-2.6 |
-0.9 |
-88 |
RH12 | RH12 | 4 |
4 |
2 |
2.42 |
-0.44 |
-15.4 |
-1.9 |
-0.4 |
-64 |
1.57 |
-0.43 |
-21.5 |
-2.7 |
-0.9 |
-90 |
RH19 | RH19 | 3 |
4 |
2 |
2.70 |
-0.16 |
-5.6 |
-0.7 |
0.3 |
-23 |
1.77 |
-0.23 |
-11.5 |
-1.4 |
-0.2 |
-48 |
RH20 | RH20 | 5 |
4 |
7 |
2.31 |
-0.55 |
-19.2 |
-2.4 |
-0.6 |
-80 |
1.71 |
-0.29 |
-14.5 |
-1.8 |
-0.4 |
-60 |
CL005 | CL005 | 7 |
4 |
9 |
3.05 |
0.19 |
6.6 |
0.8 |
1.0 |
28 |
2.04 |
0.04 |
2.0 |
0.3 |
0.8 |
8 |
CL006a | CL006 | 8 |
4 |
7 |
2.34 |
-0.52 |
-18.2 |
-2.3 |
-0.6 |
-75 |
1.75 |
-0.25 |
-12.5 |
-1.6 |
-0.3 |
-52 |
CL008 | CL008 | 4 |
4 |
2 |
2.64 |
-0.22 |
-7.7 |
-1.0 |
0.1 |
-32 |
1.76 |
-0.24 |
-12.0 |
-1.5 |
-0.2 |
-50 |
CL011 | CL011 | 0 |
4 |
13 |
3.04 |
0.18 |
6.3 |
0.8 |
1.0 |
26 |
2.16 |
0.16 |
8.0 |
1.0 |
1.2 |
33 |
CL014b | CL014 | 5 |
4 |
1 |
1.96 |
-0.90 |
-31.5 |
-3.9 |
-1.4 |
-130 |
1.58 |
-0.42 |
-21.0 |
-2.6 |
-0.9 |
-88 |
Median of CLIA Group |
2.58 |
1.76 |
||||||||||||||
Range of CLIA Group |
1.96 - 3.07 |
1.57 - 2.19 |
||||||||||||||
Robust mean of CLIA Group |
2.59 ( n = 12 ) |
1.82 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.44 |
0.28 |
||||||||||||||
CV of CLIA Group |
17.0% |
15.4% |
||||||||||||||
Median of European CLIA Labs |
2.93 ( n = 1026 ) |
2.01 ( n = 1020 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.22 - 3.14 |
1.63 - 2.18 |
||||||||||||||
Median of All Labs |
2.58 |
1.81 |
||||||||||||||
Range of All Labs |
1.96 - 3.84 |
1.57 - 2.19 |
||||||||||||||
Robust mean of All Labs |
2.66 ( n = 21 ) |
1.86 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.47 |
0.26 |
||||||||||||||
CV of All Labs |
17.7% |
14.0%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.86 |
2.00 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.24 - 3.14 |
1.62 - 2.18 |
||||||||||||||
Mean of All European Labs |
2.74 ( n = 1197 ) |
1.92 ( n = 1180 ) |
||||||||||||||
SD of All European Labs |
0.436 |
0.25 |
||||||||||||||
CV of All European Labs |
16.0% |
12.9% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.229 |
0.16 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2016-11-02